|
House Bill 1584 |
House Author: Thompson, Senfronia et al. |
|
Effective: 9-1-19 |
Senate Sponsor: Buckingham et al. |
House Bill 1584 amends the Insurance Code to prohibit a health benefit plan that provides coverage for stage-four advanced, metastatic cancer and associated conditions from requiring that an enrollee fail to successfully respond to a different drug or prove a history of such failure before the plan provides coverage of an FDA-approved prescription drug used for the treatment of the cancer or condition.